ARTICLE | Financial News
VaxGen raises $20 million
May 24, 2001 7:00 AM UTC
VXGN, a developer of HIV/AIDS vaccines, raised $20 million in a private placement of series A 6% cumulative convertible preferred stock. The preferred stock is convertible into common shares at $23.22...